Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
about
Role of sulfatide in normal and pathological cells and tissuesGene therapy for metachromatic leukodystrophy.Four novel ARSA gene mutations with pathogenic impacts on metachromatic leukodystrophy: a bioinformatics approach to predict pathogenic mutationsLentivector integration sites in ependymal cells from a model of metachromatic leukodystrophy: non-B DNA as a new factor influencing integration.Metachromatic leukodystrophy: a case of triplets with the late infantile variant and a systematic review of the literature.Disease specific therapies in leukodystrophies and leukoencephalopathies.Sulfatide levels correlate with severity of neuropathy in metachromatic leukodystrophyNovel candidate disease for gene therapy: metachromatic leukodystrophy.National variation in costs and mortality for leukodystrophy patients in US children's hospitalsThe spectrum of leukodystrophies in children: Experience at a tertiary care centre from North IndiaDirect tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy.Inherited metabolic disorders involving the eye: a clinico-biochemical perspective.Adult metachromatic leukodystrophy treated by allo-SCT and a review of the literature.Haematopoietic stem cell transplantation does not retard disease progression in the psycho-cognitive variant of late-onset metachromatic leukodystrophy.Emerging treatments for pediatric leukodystrophies.Current Perspective of Stem Cell Therapy in Neurodegenerative and Metabolic Diseases.Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy.The natural course of gross motor deterioration in metachromatic leukodystrophy.Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy.AAVrh.10-mediated APOE2 CNS Gene Therapy for APOE4-associated Alzheimer's Disease.Toxic, Metabolic and Physical Insults to the Nervous System and Inherited Disorders of Metabolism
P2860
Q28267288-EEDDD009-9835-447B-96DB-16B1D1E5C5A2Q30357745-83902806-1F1F-4AF2-8439-67B6E701D31BQ33828753-103BB54F-3559-4802-9D59-E4C1F924C96AQ34459397-7FF5EF3A-40D5-4C4C-B36D-58F42D162A14Q34615254-5AD65125-AA95-4D12-A8A4-3101306E62B9Q35328494-B2B86EBE-660A-452B-AC3E-58B9EDB2ED55Q35619201-016D1107-77F9-43A4-B45E-2291C77F65A9Q36909371-3A530220-BC0B-405C-BB0F-98AD7A2C9EFCQ37108450-9388A438-5C4A-4F0C-8700-B7DCBBC8F197Q37167356-1C2EFDA5-3805-4FC9-90EF-40685F63C4A5Q37250278-C7D6EE94-2C4B-4FC6-B0B3-2C1603C777B9Q37607099-372086DB-1F1C-4FD7-BFDF-6DD1555DC985Q37806061-736717D1-5116-495F-8D1D-B555382ACB2BQ37809802-F2816197-D886-4422-98BB-1E2C84500CECQ38506539-DA31A05A-8952-4BCC-AFC5-E6F0D9BA2F6BQ38999340-0A4989BB-8782-4821-84DB-E585458A8919Q40088069-7DE87C5A-EF5F-4C82-81BC-F6148821990CQ42431886-A7E74C47-3D63-4D5E-8F1A-89D056587EE8Q44620592-91F15E85-6131-46C0-B696-C62E80776F1CQ46501666-2E26DCEA-8225-4178-95F3-06065FDFA97EQ48510056-810D9BB3-50FF-4B31-888F-4170DA8EE788Q57539383-863A0804-806F-46B3-84A3-C3B8E08F34EE
P2860
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
@ast
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
@en
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
@nl
type
label
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
@ast
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
@en
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
@nl
prefLabel
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
@ast
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
@en
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
@nl
P2093
P3181
P1476
Enzyme, cell and gene-based therapies for metachromatic leukodystrophy
@en
P2093
P2888
P304
P3181
P356
10.1007/S10545-007-0540-Z
P407
P577
2007-04-01T00:00:00Z
P6179
1041555629